Literature DB >> 11489971

Signaling through TNF receptor p55 in TNF-alpha-deficient mice alters the CXCL13/CCL19/CCL21 ratio in the spleen and induces maturation and migration of anergic B cells into the B cell follicle.

L Mandik-Nayak1, G Huang, K C Sheehan, J Erikson, D D Chaplin.   

Abstract

The organization of secondary lymphoid tissues into distinct T and B cell compartments supports proper regulation of an immune response to foreign Ags. In the splenic white pulp, this compartmentalization is also thought to be important in the maintenance of B cell tolerance. Using lymphotoxin-alpha-(LT-alpha)-, TNF-alpha-, or TNFRp55-deficient mice, all with disrupted splenic architecture, we tested whether normal T/B segregation and/or intact follicular structure are necessary for the maintenance of anti-dsDNA B cell anergy. This study demonstrates that anti-dsDNA B cells remain tolerant in LT-alpha(-/-), TNF-alpha(-/-), and TNFRp55(-/-) mice; however, TNF-alpha or a TNF-alpha-dependent factor is required for their characteristic positioning to the T/B interface. Providing a TNF-alpha signal in TNF-alpha(-/-) mice by systemic administration of an agonist anti-TNFRp55 mAb induces the maturation of the anti-dsDNA B cells and their movement away from the T cell area toward the B cell area. Additionally, the agonist Ab induces changes in the follicular environment, including FDC clustering, up-regulation of the CXC chemokine ligand CXCL13, and down-regulation of the CC chemokine ligands CCL19 and CCL21. Therefore, this study suggests that a balance between B and T cell tropic chemokine signals may be an important mechanism for positioning anergic B cells at the T/B interface of the splenic white pulp.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11489971     DOI: 10.4049/jimmunol.167.4.1920

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Lymphotoxin-beta receptor blockade induces inflammation and fibrosis in tolerized cardiac allografts.

Authors:  Y Nakayama; J S Bromberg
Journal:  Am J Transplant       Date:  2012-05-17       Impact factor: 8.086

2.  Gamma interferon blocks gammaherpesvirus reactivation from latency.

Authors:  Ashley L Steed; Erik S Barton; Scott A Tibbetts; Daniel L Popkin; Mary L Lutzke; Rosemary Rochford; Herbert W Virgin
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 3.  B-lymphocyte tolerance and effector function in immunity and autoimmunity.

Authors:  Wasif N Khan; Jacqueline A Wright; Eden Kleiman; Justin C Boucher; Iris Castro; Emily S Clark
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

4.  Efficient colonic mucosal wound repair requires Trem2 signaling.

Authors:  Hiroshi Seno; Hiroyuki Miyoshi; Sarah L Brown; Michael J Geske; Marco Colonna; Thaddeus S Stappenbeck
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-24       Impact factor: 11.205

5.  The lymphotoxin LTalpha(1)beta(2) controls postnatal and adult spleen marginal sinus vascular structure and function.

Authors:  Carlene L Zindl; Tea Hyun Kim; Meiqin Zeng; Angela S Archambault; Mitchell H Grayson; Kyunghee Choi; Robert D Schreiber; David D Chaplin
Journal:  Immunity       Date:  2009-03-20       Impact factor: 31.745

6.  The adjuvant LT-K63 can restore delayed maturation of follicular dendritic cells and poor persistence of both protein- and polysaccharide-specific antibody-secreting cells in neonatal mice.

Authors:  Stefania P Bjarnarson; Brenda C Adarna; Hreinn Benonisson; Giuseppe Del Giudice; Ingileif Jonsdottir
Journal:  J Immunol       Date:  2012-07-02       Impact factor: 5.422

7.  A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritis.

Authors:  Katie Bechman; Anthony Dalrymple; Charles Southey-Bassols; Andrew P Cope; James B Galloway
Journal:  BMC Rheumatol       Date:  2020-11-02

8.  CXCL13/CXCR5 axis facilitates endothelial progenitor cell homing and angiogenesis during rheumatoid arthritis progression.

Authors:  Chun-Hao Tsai; Chao-Ju Chen; Chi-Li Gong; Shan-Chi Liu; Po-Chun Chen; Chien-Chung Huang; Sung-Lin Hu; Shih-Wei Wang; Chih-Hsin Tang
Journal:  Cell Death Dis       Date:  2021-09-13       Impact factor: 8.469

9.  CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic 'window of opportunity'.

Authors:  Stinne Ravn Greisen; Karen Kræmmer Schelde; Tue Kruse Rasmussen; Tue Wenzel Kragstrup; Kristian Stengaard-Pedersen; Merete Lund Hetland; Kim Hørslev-Petersen; Peter Junker; Mikkel Østergaard; Bent Deleuran; Malene Hvid
Journal:  Arthritis Res Ther       Date:  2014-09-24       Impact factor: 5.156

Review 10.  STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development.

Authors:  Jessica N Filderman; Mark Appleman; Manoj Chelvanambi; Jennifer L Taylor; Walter J Storkus
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.